The nation’s leading doctors groups are in a standoff with federal health officials over vaccines. The conflict intensified when an advisory panel, handpicked by Health
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene